Lakefront Biotherapeutics NV
LKFT· Nasdaq
Lakefront Biotherapeutics NV
- Last sale
- Oct 2, 2026 · +1.77%
- Market cap
- $1.94B
- 65.9M shares
- Filings
- 538
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | €1,112,248,000 | reported | |
| FY 2024 | 2024-12-31 | €275,649,000 | reported | |
| FY 2023 | 2023-12-31 | €239,724,000 | reported | |
| FY 2022 | 2022-12-31 | €241,249,000 revised | reported | |
| FY 2021 | 2021-12-31 | €234,384,000 revised | reported | |
| FY 2020 | 2020-12-31 | €478,053,000 | reported | |
| FY 2019 | 2019-12-31 | €834,901,000 revised | reported | |
| FY 2018 | 2018-12-31 | €278,666,000 revised | reported | |
| FY 2017 | 2017-12-31 | €127,087,000 | reported | |
| FY 2016 | 2016-12-31 | €129,519,000 | reported | |
| FY 2015 | 2015-12-31 | €39,563,000 | reported |
Lakefront Biotherapeutics NV · CIK 1421876 · Engraved from SEC EDGAR
